pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Apr 30·1 min read
save

NIH grant success rates hit historic low, pushing researchers to seek alternative funding

Apr 30, 2026·read at STAT ↗Negative

NIH grant success rates have fallen to historic lows, with only about 13% of applications receiving funding in the most recent fiscal year.

Researchers are responding by dedicating more time to writing proposals, submitting a higher volume of applications, and seeking alternative funding sources or reshaping projects to match current administration priorities.

Clinician-scientists, such as those at the University of Michigan, report increasing pressure to spend more time on patient care, which can divert attention from research activities.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Securing NIH awards is getting more competitive — and confusing”

read at STAT ↗
2,557 words · retrieved Apr 30
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Emory UniversityNational Institutes of HealthPATHUniversity of Washington
topics
KRASOncology

related stories

  • 2d agoBreast cancer can behave differently in older women. This physician is making more tailored treatments a realitySTAT
  • Oct 2NIH rolling out streamlined website to help public find information more easilySTAT
  • Sep 145 drugmakers chasing Merck and Moderna in the cancer vaccine raceBioSpace
  • Aug 13PDS halts work on phase 3 cancer therapy to focus on colorectal contenderFierce Biotech
  • Jul 29Opinion: The VA could help America win the biotechnology race with ChinaSTAT